GRAFT VERSUS HOST-DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION

被引:24
作者
CHAO, NJ
机构
[1] Stanford University, Medical Center, Stanford, CA
关键词
D O I
10.1016/0952-7915(92)90028-D
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Graft versus host disease is a major barrier in allogeneic bone marrow transplantation. The associated morbidity and mortality need to be understood and prevented if possible, as the potential indications for bone marrow transplantation continue to broaden. Areas of investigation include the cellular effector arm as well as the cytokines associated with the expression of the disease.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 40 条
[1]  
ANTIN JH, 1991, BLOOD, V78, P2139
[2]   DONOR MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) PEPTIDES ARE PRESENTED BY RECIPIENT MHC MOLECULES DURING GRAFT-REJECTION [J].
BENICHOU, G ;
TAKIZAWA, PA ;
OLSON, CA ;
MCMILLAN, M ;
SERCARZ, EE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :305-308
[3]  
Billingham R E, 1966, Harvey Lect, V62, P21
[4]  
CLAVERIE JM, 1986, ANN INST PASTEUR IMM, VD137, P425
[5]  
COHN ML, 1991, BLOOD, V78, P3317
[6]  
COOPER MH, 1991, TRANSPLANT P, V23, P3238
[7]  
DERUYSSCHER D, 1991, J IMMUNOL, V146, P4065
[8]  
FORMAN SJ, 1987, TRANSPLANT P, V19, P2605
[9]   BONE-MARROW TRANSPLANTATION FOR ACUTE NONLYMPHOBLASTIC LEUKEMIA DURING 1ST COMPLETE REMISSION - AN ANALYSIS OF PROGNOSTIC FACTORS [J].
FORMAN, SJ ;
KRANCE, RA ;
ODONNELL, MR ;
NADEMANEE, AP ;
SNYDER, DS ;
FAHEY, JL ;
SCHMIDT, GM ;
ZAIA, JA ;
LIPSETT, JA ;
FINDLEY, DO ;
SNIECINSKI, IJ ;
METTER, GE ;
HILL, LR ;
NATHWANI, MB ;
BLUME, KG .
TRANSPLANTATION, 1987, 43 (05) :650-653
[10]   REDUCTION IN THE SEVERITY OF GRAFT-VERSUS-HOST DISEASE AND INCREASED SURVIVAL IN ALLOGENEIC MICE BY TREATMENT WITH MONOCLONAL-ANTIBODIES TO CELL-ADHESION ANTIGENS LFA-1-ALPHA AND MALA-2 [J].
HARNING, R ;
PELLETIER, J ;
LUBBE, K ;
TAKEI, F ;
MERLUZZI, VJ .
TRANSPLANTATION, 1991, 52 (05) :842-845